US Patent Issued to PHARMA-DATA RESEARCH AND DEVELOPMENT SINGLE MEMBER on Feb. 4 for "Apixaban suspension and preparation method" (Greek Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,214,075, issued on Feb. 4, was assigned to PHARMA-DATA RESEARCH AND DEVELOPMENT SINGLE MEMBER S.A. (Lavrio, Greece).

"Apixaban suspension and preparation method" was invented by Ioannis Psarrakis (Lavrion, Greece) and Konstantinos Lioumis (Lavrion, Greece).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention describes a buffered oral aqueous apixaban suspension comprising 0.08-0.20 w/v % micronized apixaban having a pH of 1.5-6.5 and a method for the preparation thereof."

The patent was filed on Oct. 25, 2022, under Application No. 18/703,824.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/net...